Author

P. Betancur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Approach:benchmark study· 1 Approach:biophysical modeling· 1

Frequent Co-Authors

C. Di Benedetto· 1 shared G. P. Nolan· 1 shared G. Valdes· 1 shared G. Wernig· 1 shared J. Oh· 1 shared J.-W. Lee· 1 shared L. Cui· 1 shared P. Domizi· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

C. Di Benedetto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivApr 1, 2022

NSMCE2, a Novel Super-Enhancer Regulated Gene, is Linked to Poor Prognosis and Therapy Resistance in Breast Cancer

C. Di Benedetto, J. Oh, Z. Choidhery…·P. Betancur

This study identifies NSMCE2 as a super-enhancer regulated gene linked to poor prognosis and therapy resistance in breast cancer, showing that targeting it can enhance chemotherapy effectiveness.

DOI 10.1186/s12885-022-10157-7

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivMar 18, 2020

Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity

L. Cui, S.-Y. Chen, T. Lerbs…·G. Wernig

This study shows JUN activation in fibroblasts drives fibrosis and modulates immunity, with therapeutic potential through targeting IL-6, CD47, and PD-L1.

DOI 10.1038/s41467-020-16466-4

mousehuman

𝕏 PostBluesky